Bhupesh Pratap

Bhupesh Pratap possesses extensive experience in pharmacokinetics and formulation development within the pharmaceutical industry. Currently serving as Clinical Manager at Rosemont Pharmaceuticals since March 2022, Bhupesh supports in-house and international R&D initiatives, focusing on early-phase and late clinical development, as well as leading PBPK modeling for regulatory submissions. Prior to this role, Bhupesh held several positions at Perrigo Company plc, where significant achievements included reducing ANDA filing times and contributing to numerous successful NDA and 505(b)(2) applications. Experience also includes key roles at Glenmark Generics Ltd., Astron Research Limited, and Dr. Reddy's Laboratories, where Bhupesh established pharmacokinetics teams, optimized dosage forms, and implemented biopharmaceutical strategies, showcasing a strong capability in leveraging scientific knowledge to drive product development. Educational qualifications include an M.S. in Pharmacology and Toxicology from the National Institute of Pharmaceutical Education and Research and a B.Pharm from BBDNITM, Lucknow.